Evidence map›Paper›PMID 37572740›Full record

Observational studyThe American journal of medicine2023

Clinical Significance of Right Heart Thrombus With and Without an Associated Pulmonary Embolism.

Nathan W Watson, Ido Weinberg, Andrew B Dicks, Esmond Fong, Jordan B Strom, Brett J Carroll, Aishwarya Raja, Robert Schainfeld, Eric A Secemsky

Open access · greenAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in The American journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Retrospective Analysis of AngioVac Outcomes at a Tertiary Care Center.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Nathan W WatsonHarvard Medical School, Boston, Mass; Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass.
Ido WeinbergHarvard Medical School, Boston, Mass; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Andrew B DicksHarvard Medical School, Boston, Mass; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Esmond FongHarvard Medical School, Boston, Mass; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Jordan B StromHarvard Medical School, Boston, Mass; Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass.
Brett J CarrollHarvard Medical School, Boston, Mass; Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass.
Aishwarya RajaSmith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass.
Robert SchainfeldHarvard Medical School, Boston, Mass; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
Eric A SecemskyHarvard Medical School, Boston, Mass; Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass. Electronic address: esecemsk@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USHarvard University · US

Funding

Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)R01HL169517 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Jordan Blair Strom · 2023 to 2026
$3.1M
Identification of the Components of Frailty Using Administrative Data and Metabolite ProfilingK23HL144907 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STROM, JORDAN BLAIR · 2019 to 2023
$1.0M
Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment DecisionsK23HL150290 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SECEMSKY, ERIC ALEXANDER · 2020 to 2024
$851k
NHLBI NIH HHS K23 HL144907NHLBI NIH HHS K23 HL150290NHLBI NIH HHS R01 HL169517
6 · The paper itself

Abstract

backgroundRight heart thrombus is a rare but serious form of venous thromboembolic disease that may be associated with pulmonary embolism. The prognosis of patients with right heart thrombus presenting without a concomitant pulmonary embolism remains ill-defined.

methodsWe conducted a multi-center observational cohort study to compare patients presenting with right heart thrombus with and without a concurrent pulmonary embolism. The primary endpoint was 90-day all-cause mortality. Multivariable regression was utilized to assess primary and secondary outcomes.

resultsOf 231 patients with right heart thrombus, 104 (45.0%) had a pulmonary embolism at admission. The median age of the cohort was 59.4 years (interquartile range 44.9-71.3). Pulmonary embolism in the setting of a right heart thrombus was associated with an increased adjusted hazard of 90-day mortality (hazard ratio 3.68; 95% confidence interval [CI], 1.51-8.97). Additionally, these patients had a higher adjusted risk of in-hospital mortality (odds ratio [OR] 2.55; 95% CI, 1.15-5.94) and admission to the intensive care unit (OR 2.45; 95% CI, 1.23-4.94). Thrombus mobility (OR 2.99; 95% CI, 1.35-6.78) and larger thrombus sizes (OR 1.04; 95% CI, 1.00-1.07) were associated with development of concurrent pulmonary embolism.

conclusionsPatients with right heart thrombus and pulmonary embolism had a more severe clinical presentation, required more advanced therapies, and had reduced survival compared with those without a concomitant pulmonary embolism. Important variables associated with development of concomitant pulmonary embolism include thrombus mobility and size. Right heart thrombus in the setting of acute pulmonary embolism represents a unique clinical entity that is associated with worse prognosis compared with right heart thrombus only.

Indexed as

Heart DiseasesPulmonary EmbolismThrombosisAdultAgedClinical RelevanceCohort StudiesFemaleHospital MortalityHumansMaleMiddle AgedPrognosisAnticoagulationPulmonary embolismRight heart thrombusThrombusVenous thromboembolism

Identifiers

PMID37572740
PMCPMC10592144
OpenAlexW4385728829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.